Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study

Abstract

Purpose Older adults are vulnerable to chemotherapy toxicity; however, there are limited data to identify those at risk. The goals of this study are to identify risk factors for chemotherapy toxicity in older adults and develop a risk stratification schema for chemotherapy toxicity. Patients and Methods Patients age ≥ 65 years with cancer from seven institutions completed a prechemotherapy assessment that captured sociodemographics, tumor/treatment variables, laboratory test results, and geriatric assessment variables (function, comorbidity, cognition, psychological state, social activity/support, and nutritional status). Patients were followed through the chemotherapy course to capture grade 3 (severe), grade 4 (life-threatening or disabling), and grade 5 (death) as defined by the National Cancer Institute Common Terminology Criteria for Adverse Events. Results In total, 500 patients with a mean age of 73 years (range, 65 to 91 years) with stage I to IV lung (29%), GI (27%), gynecologic (17%), breast (11%), genitourinary (10%), or other (6%) cancer joined this prospective study. Grade 3 to 5 toxicity occurred in 53% of the patients (39% grade 3, 12% grade 4, 2% grade 5). A predictive model for grade 3 to 5 toxicity was developed that consisted of geriatric assessment variables, laboratory test values, and patient, tumor, and treatment characteristics. A scoring system in which the median risk score was 7 (range, 0 to 19) and risk stratification schema (risk score: percent incidence of grade 3 to 5 toxicity) identified older adults at low (0 to 5 points; 30%), intermediate (6 to 9 points; 52%), or high risk (10 to 19 points; 83%) of chemotherapy toxicity (P < .001). Conclusion A risk stratification schema can establish the risk of chemotherapy toxicity in older adults. Geriatric assessment variables independently predicted the risk of toxicity.

Fall-related injuries in elderly cancer patients treated with neurotoxic chemotherapy: A retrospective cohort study

“…15 In another prospective longitudinal study, patients with a history of a fall in the 6 months prior to starting chemotherapy were more likely to experience grade 3-5 toxicities from chemotherapy. 16 Falls and FRIs appear to play an important role in the treatment outcomes of elderly patients with chemotherapy, but there is little information in the literature about how often these events occur and which patients are at greatest risk. The primary aim of this retrospective cohort study was to describe the prevalence of fall-related injuries in a specific population of elderly patients with cancer.…”

Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma in Older Adults

“…High-risk versus low-risk patients identified by the CARG toxicity tool had an 89% versus 25% risk respectively of severe chemotherapy toxicity, in contrast with provider-reported Karnofsky Performance Status, which did not predict toxicity. 41 Another model, the Chemotherapy Risk Assessment Scale for High-Age Patients Dexamethasone Prednisone a A combination of drugs is commonly used in the relapsed/refractory setting and the choice of drug combinations is based on previous treatments' efficacy and tolerability, patient-related factors, and perceived disease aggressiveness, among many other factors.…”

Glioblastoma in the elderly — How do we choose who to treat?

“…Multi-dimensional geriatric assessment has been shown to predict for tolerance to treatment and survival in other tumour types [6]. It is apparent that the assessment tools used in oncology patients with extra-cranial malignancies are likely to be less valid within the GBM cohort because of the unique and potentially isolated deficits caused by the disease itself.…”